1-11 of 11
Maria Jose Calasanz, BSc, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transcriptomic Profiling of Circulating Tumor Cells (CTCs) in Multiple Myeloma (MM): A New Model to Understand Disease Dissemination

Juan José Garcés, Michal Šimíček, Marco Vicari, Lucie Brozova, MSc, Leire Burgos, Renata Bezděková, MSc., Diego Alignani, PhD, Maria Jose Calasanz, BSc, PhD, Katerina Growkova, Ludek Pour, MD, Rafael Rios, MD PhD, Joaquin Martinez-Lopez, MD PhD, Pamela Millacoy, Luis Palomera, MD PhD, Rafael Del Orbe, Sonia Garate, Laura Blanco, Patricia Maiso, PhD, Zuzana Chyra, Alexander Vdovin, Tomas Jelinek, Cirino Botta, MD, Halima El Omri, Xabier Agirre, PhD, Felipe Prosper, MD PhD, Roman Hajek, MD PhD, Jesus F San-Miguel, MD PhD, Bruno Paiva, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 245.
https://doi.org/10.1182/blood-2018-99-113331
Published: 2018
Journal Articles

Curativestategy (GEM-CESAR) for High-Risk Smoldering Myeloma (SMM): Carfilzomib, Lenalidomide and Dexamethasone (KRd) As Induction Followed By HDT-ASCT, Consolidation with Krd and Maintenance with Rd

Maria-Victoria Mateos, MD PhD, Joaquin Martínez-López, MD PhD, Paula Rodriguez Otero, MD, Enrique M. Ocio, MD, Marta Sonia Gonzalez, MD, Albert Oriol, MD, Norma C. Gutierrez, MD PhD, Bruno Paiva, MD PhD, Rafael Rios, MD PhD, Laura Rosinol, MD PhD, Miguel Angel Alvarez, MD, Maria Jose Calasanz, BSc, PhD, Joan Bargay, MD PhD, Ana Pilar Gonzalez, PhD, Adrián Alegre, MD, Fernando Escalante, MD, Rafael Martínez, Noemi Puig, MD PhD, Javier De La Rubia, MD, Ana Isabel Teruel, MDcal Doctor, María Teresa Cedena, Felipe De Arriba, PhD, Luis Palomera, MD PhD, Miguel T Hernández, MD PhD, Javier Lopez Jimenez, MD PhD, Jesús Martín, Esther Piensa, Aránzazu García Mateo, PhD, Veronica Gonzalez De La Calle, MD PhD, Joan Bladé, MD PhD, Juan Jose Lahuerta, MD PhD, Jesus F San-Miguel, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2142.
https://doi.org/10.1182/blood-2018-99-112656
Published: 2018
Journal Articles

Immunofixation (IF) in Urine Is Really Necessary to Define Complete Remission in Multiple Myeloma (MM)? a Subanalysis from the Pethema/GEM2012MENOS65 Phase III Clinical Trial

Ana Jiménez Ubieto, MD PhD, Bruno Paiva, MD PhD, Joaquin Martínez-López, MD PhD, Laura Rosinol, MD PhD, Maria Teresa Cedena Romero, MD PhD, Maria Jose Calasanz, BSc, PhD, Noemi Puig, MD PhD, Ramon Garcia-Sanz, MD PhD, Norma C. Gutierrez, MD PhD, Maria Luisa Martin-Ramos, Albert Oriol, MD, José Gonzalez Medina, Rafael Alonso Fernandez, Jesús Blanchard, MD, Rafael Rios, MD PhD, Jesús Martín, Rafael Martinez Martinez, Josep Sarra, Miguel-Teodoro Hernández, Javier De La Rubia, MD, Isabel Krsnik, MD PhD, Jose Maria Moraleda, Luis Palomera, MD PhD, Maria-Victoria Mateos, MD PhD, Jesús F San-Miguel, MD, Joan Bladé, MD, Juan-José Lahuerta, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 474.
https://doi.org/10.1182/blood-2018-99-115050
Published: 2018
Journal Articles

Clinical Significance and Transcriptional Profiling of Persistent Minimal Residual Disease (MRD) in Multiple Myeloma (MM) Patients with Standard-Risk (SR) and High-Risk (HR) Cytogenetics

Ibai Goicoechea, PhD, Noemi Puig, MD PhD, María Teresa Cedena, Lourdes Cordon, Maria-Belen Vidriales, MD, Leire Burgos, Juan Flores-Montero, Norma C. Gutierrez, MD PhD, Maria Jose Calasanz, BSc, PhD, Maria Luisa Martin-Ramos, David Lara-Astiaso, PhD, Amaia Vilas-Zornoza, PhD, Diego Alignani, PhD, Idoia Rodriguez, Sarai Sarvide, Ramon Garcia-Sanz, MD PhD, Joaquin Martinez-Lopez, MD PhD, Albert Oriol, MD, Rafael Rios, MD PhD, Jesús Martín, Rafael Martínez, Josep Sarra, Miguel T Hernández, MD PhD, Javier De La Rubia, MD, Isabel Krsnik, Jose Maria Moraleda, Luis Palomera, MD PhD, Joan Bargay, MD PhD, Alberto Orfao, MD PhD, Laura Rosiñol, Maria-Victoria Mateos, MD PhD, Juan Jose Lahuerta, MD PhD, Joan Bladé, MD PhD, Jesus F San-Miguel, MD PhD, Bruno Paiva, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 112.
https://doi.org/10.1182/blood-2018-99-113312
Published: 2018
Journal Articles

Absence of Contribution to a Differential Outcome of the Stringent Complete Response IMWG Category Respect to the Conventional CR in Multiple Myeloma. a Validation Analysis Based on the Pethema/GEM2012MENOS65 Phase III Clinical Trial

Ana Jiménez Ubieto, MDPhD, Joaquin Martinez Lopez, MD PhD, Laura Rosinol, MD PhD, Bruno Paiva, MD PhD, María Teresa Cedena, Noemi Puig, MD PhD, Maria Jose Calasanz, BSc, PhD, José Gonzalez Medina, Maria Luisa Martin-Ramos, Rafael Alonso Fernandez, Albert Oriol, MD, Jesús Blanchard, MD, Enrique M. Ocio, MD, Javier De La Rubia, MD, Rafael Rios, MD PhD, Jesús Martín, Miguel-Teodoro Hernández, Isabel Krsnik, MD PhD, Jose Maria Moraleda, Luis Palomera, MD PhD, Joan Bargay, MD PhD, Maria-Victoria Mateos, MD PhD, Jesús F San-Miguel, MD, Joan Bladé, MD, Juan-José Lahuerta, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1943.
https://doi.org/10.1182/blood-2018-99-116604
Published: 2018
Journal Articles

Impact of Next-Generation Flow (NGF) Minimal Residual Disease (MRD) Monitoring in Multiple Myeloma (MM): Results from the Pethema/GEM2012 Trial

Bruno Paiva, PhD, Noemi Puig, MD PhD, Maria Teresa Cedena, Lourdes Cordon, Maria-Belen Vidriales, Leire Burgos, Juan Flores-Montero, Lucía Lopez-Anglada, Norma Gutierrez, MD PhD, Maria Jose Calasanz, BSc, PhD, Maria Luisa Martin-Ramos, Ramon Garcia-Sanz, MD PhD, Joaquin Martinez-Lopez, MD PhD, Albert Oriol, MD, M Jesús Blanchard, Rafael Rios, Jesús Martín, Rafael Martínez, Josep Sarra, Miguel T Hernández, Javier de la Rubia, Isabel Krsnik, Jose M Moraleda, Luis Palomera, Juan Bargay, Alberto Orfao, MD PhD, Laura Rosinol, MD PhD, Maria-Victoria Mateos, MD, Juan-José Lahuerta, Joan Bladé, MD PhD, Jesus F. San Miguel, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 905.
https://doi.org/10.1182/blood.V130.Suppl_1.905.905
Published: 2017
Journal Articles

New Alternatives for the Evaluation of Minimal Residual Disease (MRD) Detection By Next Generation Sequencing in Multiple Myeloma

Alejandro Medina, BSc, Cristina Jiménez, PhD, Noemi Puig, MD PhD, Beatriz Sanchez-Vega, Juan Flores-Montero, Marcos González, MD, Maria Jose Calasanz, BSc, PhD, Rosa M. Ayala, MD PhD, Maria E Sarasquete, PhD, Bruno Paiva, PhD, Maria Teresa Cedena, Marta Fernández-Mercado, Inmaculada Rapado, Laura Rosinol, MD PhD, Enrique M. Ocio, MDPhD, Albert Oriol, MD, Miguel Alcoceba, PhD, Miguel T Hernández, Rafael Martinez Martinez, Maria-Victoria Mateos, MD, Juan-José Lahuerta, Joan Bladé, MD PhD, Alberto Orfao, MD PhD, Jesus F. San Miguel, MD, Joaquin Martínez-López, Ramón García-Sanz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1783.
https://doi.org/10.1182/blood.V130.Suppl_1.1783.1783
Published: 2017
Journal Articles

ZFP36L1, a Novel Potential Tumor Supressor Gene in Myelofibrosis, Epigenetically Deregulated By Methylation of the Enhancer Region

Nicolas Martinez-Calle, MD MSc, Marien Pascual, PhD, Raquel Ordoñez, MSc, Edurne San Jose Eneriz, PhD, Victor Segura, PhD, Giancarlo Castellano, PhD, Jose J. Rifon, MD, Maria Jose Calasanz, BSc, PhD, José I. Martin-Subero, PhD, Xabier Agirre, PhD, Felipe Prosper, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2936.
https://doi.org/10.1182/blood.V130.Suppl_1.2936.2936
Published: 2017
Journal Articles

Curative Strategy for High-Risk Smoldering Myeloma (GEM-CESAR): Carfilzomib, Lenalidomide and Dexamethasone (KRd) As Induction Followed By HDT-ASCT, Consolidation with Krd and Maintenance with Rd

Maria-Victoria Mateos, MD, Joaquin Martinez Lopez, MD PhD, Paula Rodriguez-Otero, MD PhD, Enrique M Ocio, MD, Marta Sonia Gonzalez, MD, Albert Oriol, MD, Norma Gutierrez, MD PhD, Bruno Paiva, PhD, Rafael Rios, Laura Rosinol, MD PhD, Miguel Angel Alvarez, MD, Maria Jose Calasanz, BSc, PhD, Joan Bargay, MD PhD, Ana Pilar Gonzalez, PhD, Fernando Escalante, Dr., Rafael Martínez, Noemi Puig, MD PhD, Javier de la Rubia, Ana Isabel Teruel, MD, Maria Teresa Cedena, Felipe De Arriba, PhD, Luis Palomera, Miguel T Hernández, Javier Lopez Jimenez, Jesús Martín, Esther Piensa, Aránzazu García-Mateo, Veronica González, Joan Blade, MD, Juan Jose Lahuerta, Jesus F. San Miguel, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 402.
https://doi.org/10.1182/blood.V130.Suppl_1.402.402
Published: 2017
Journal Articles

Comparison of the Molecular Spectrum of Lenalidomide-Treated Myelodysplastic Syndrome with and without Del(5q)

Vera Adema, PhD, Laura Palomo, MSc, Francisco Fuster-Tormo, MSc, Rocío Benito, PhD, Rocio Salgado, PhD, Esperanza Such, PhD, Olivier Kosmider, PharmD, PhD, Maria Jose Larrayoz, MD, Blanca Xicoy, MD, Kamila Janusz, Paolo Maietta, Alexander Neef, PhD, Beatriz Arrizabalaga Amunchastegui, MD PhD, Michaela Fontenay, MD PhD, Paula Gomez-Marzo, MSc, Monica Del Rey, PhD, Mariam Ibáñez, PhD, Nuri Haro, Mar Mallo, PhD, Lurdes Zamora, PhD, Valeria Visconte, PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Pierre Fenaux, MD PhD, Jose Cervera, MD PhD, Maria Jose Calasanz, BSc, PhD, Jesús María Hernández-Rivas, MD, Juan Cigudosa, PhD, Francesc Sole, PhD
Journal: Blood
Blood (2016) 128 (22): 3172.
https://doi.org/10.1182/blood.V128.22.3172.3172
Published: 2016
Journal Articles

HDAC Inhibitors As Novel Targeted Therapies for NUP98-HOXA9 AML Patients

Ana Rio-Machin, BSc, MSc, PhD, Gonzalo Gomez-Lopez, BSc, PhD, Alba Maiques-Diaz, BSc, MSc, PhD, Sara Alvarez, MD PhD, Maria Jose Calasanz, BSc, PhD, Jude Fitzgibbon, Juan C Cigudosa, BSc, PhD
Journal: Blood
Blood (2016) 128 (22): 2685.
https://doi.org/10.1182/blood.V128.22.2685.2685
Published: 2016